Inhibitors of Bacterial Protein Synthesis

Aminoglycosides are polycationic molecules with positively charged amino-modified sugars that bind tightly to the negatively charged phosphate backbone of ribosomal RNA. Streptomycin specifically targets the 30S subunit, binding within the decoding center around helix 44 of 16S rRNA at critical nucleotides like A1408, A1492, and A1493, disrupting proper mRNA and tRNA alignment.

When streptomycin binds to the 30S subunit, it causes conformational distortion that prevents proper alignment of mRNA and initiator tRNA, blocking formation of the functional 70S initiation complex. Ribosomes remain arrested in a non-functional pre-initiation state, halting the start of protein synthesis and preventing normal translation initiation.

Aminoglycosides stabilize an aberrant flipped-out state of ribosomal nucleotides, permitting incorrect codon-anticodon pairing and incorporation of wrong amino acids into proteins. These misfolded or truncated proteins insert into the bacterial cell membrane, altering its permeability and causing ion leakage, collapse of the proton motive force, and ultimately cell death.

Streptomycin can lock ribosomes in an inactive conformation during elongation, halting the elongation phase and preventing ribosome recycling after translation termination. This interference with EF-G-mediated translocation and the concerted actions of RRF and EF-G required to dissociate the 70S complex results in ribosome stalling and sequestration of translational machinery.

Aminoglycosides are bactericidal because they actively kill bacteria through multiple mechanisms: disrupting initiation, causing translational errors, and blocking ribosome recycling. The resulting misintegrated membrane proteins compromise membrane integrity, leading to ion leakage, ATP depletion, and cell death, distinguishing them from bacteriostatic agents that merely inhibit growth.

Aminoglycosides consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate electrostatic interactions with the negatively charged phosphate backbone of ribosomal RNA, enabling tight binding specifically at the 16S rRNA of the 30S subunit.

Bacteria have evolved multiple resistance mechanisms including enzymatic drug modification that inactivates the antibiotic, target methylation that alters ribosomal RNA binding sites, ribosomal mutations that prevent drug binding, and reduced drug uptake that limits antibiotic access to the ribosome. Understanding these mechanisms informs the clinical significance of antibiotic resistance.